EcoDrugPlus

Somatostatin Receptor 2

Ensembl ID : ENSACIG00000020404
Gene Symbol: SSTR2
1 Cross references
192 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSACIG00000013880
Gene Symbol: SSTR5
1 Cross references
187 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSACIG00000010462
Gene Symbol: SYK
1 Cross references
203 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSACIG00000007474
Gene Symbol: SRD5A2B
1 Cross references
192 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSACIG00000008124
Gene Symbol: SOAT1
1 Cross references
211 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSACIG00000014147
Gene Symbol: TACR1
1 Cross references
214 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSACIG00000006986
Gene Symbol: TACR2
1 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSACIG00000001663
Gene Symbol: TACR3
2 Cross references
172 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSACIG00000020800
Gene Symbol: TACR3L
1 Cross references
201 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSACIG00000017564
Gene Symbol: TERT
1 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSACIG00000009700
Gene Symbol: TBXAS1
1 Cross references
215 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSACIG00000009665
Gene Symbol: TBXAS1
1 Cross references
208 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).